WINNERS & LOSERS: Vanquis cuts outlook; Zoo Digital loss narrows
30th Jul 2026 11:20
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday. Read More
| Price | 4.75p on 14-10-2026 at 18:35:05 |
|---|---|
| Change | 0.00p 0% |
| Buy | 5.00p |
| Sell | 4.50p |
| Last Trade: | Sell 1,938.00 at 4.67p |
| Day's Volume: | 48,323 |
| Last Close: | 4.75p |
| Open: | 4.75p |
| ISIN: | GB00B02LCQ05 |
| Day's Range | 4.75p - 4.75p |
| 52wk Range: | 4.75p - 12.10p |
| Market Capitalisation: | £300.80m |
| VWAP: | 4.507025p |
| Shares in Issue: | 6.33b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Allergy Thera. (AGY) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 1,938 | 4.67p | Ordinary |
13:00:59 - 14-Oct-26 |
| Buy* | 20 | 5.00p | SI Trade |
09:37:14 - 14-Oct-26 |
| Sell* | 43,365 | 4.50p | Ordinary |
08:07:05 - 14-Oct-26 |
| Sell* | 3,000 | 4.50p | Ordinary |
08:03:56 - 14-Oct-26 |
| Buy* | 415 | 5.00p | SI Trade |
15:39:45 - 13-Oct-26 |
| Unknown* | 187,167 | 4.50p | Ordinary |
15:01:10 - 13-Oct-26 |
| Sell* | 75,000 | 4.50p | Ordinary |
15:00:59 - 13-Oct-26 |
| Buy* | 717 | 5.00p | Ordinary |
10:28:08 - 13-Oct-26 |
| Buy* | 192 | 5.00p | SI Trade |
10:28:08 - 13-Oct-26 |
| Buy* | 488 | 5.00p | SI Trade |
10:28:08 - 13-Oct-26 |
Allergy Thera. (AGY) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 29th Jul 2026 7:00 am | RNS | Trading update for the year ended 30 June 2026 |
| 28th Jul 2026 7:00 am | RNS | Appointment of Executive Chairman |
| 30th Jun 2026 7:00 am | RNS | Vesting of Options under Long-Term Incentive Plan |
| 15th Jun 2026 7:00 am | RNS | Long Term Incentive Awards |
| 12th Jun 2026 7:00 am | RNS-R | Allergy Therapeutics to present at EAACI 2026 |
| 31st Mar 2026 7:00 am | RNS | Interim Results for six months ended 31 Dec 2025 |
| 12th Mar 2026 7:00 am | RNS | PDMR Dealings & Shareholding Update |
| 12th Mar 2026 7:00 am | RNS | PDMR Dealings & Shareholding Update |
| 4th Mar 2026 7:00 am | RNS | Positive Biomarker Results from PROTECT Trial |
| 26th Feb 2026 7:00 am | RNS-R | Allergy Therapeutics presents progress at AAAAI |